S100A8 and neoplasm: S100A8 activity was considerably enhanced in tumor categories BLCA, CESC, CHOL, COAD, ESCA, LUAD, LUSC, PAAD, STAD, THCA, and UCEC but remarkably decreased in tumor categories BRCA, PCPG, PRAD, and READ, as shown in Figure 3(c).